{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:51:10Z","timestamp":1790369470130,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.medcli.2026.107364","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T01:16:27Z","timestamp":1771636587000},"page":"107364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Real-world effectiveness of oral semaglutide on body weight, composition, and metabolic parameters in patients with obesity without diabetes"],"prefix":"10.1016","volume":"166","author":[{"given":"Joana","family":"Nicolau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyla","family":"Dotres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Blanco-Anesto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2026.107364_bib0105","unstructured":"[Cited Aug 2025]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight s.f."},{"key":"10.1016\/j.medcli.2026.107364_bib0110","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.recesp.2016.02.010","article-title":"Prevalence of general obesity and abdominal obesity in the Spanish adult population (aged 25\u201364 years) 2014\u20132015: the ENPE study","volume":"69","author":"Aranceta-Bartrina","year":"2016","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.medcli.2026.107364_bib0115","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/obr.12551","article-title":"Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation","volume":"18","author":"Bray","year":"2017","journal-title":"Obes Rev"},{"key":"10.1016\/j.medcli.2026.107364_bib0120","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/S0140-6736(18)32537-6","article-title":"Time for a new obesity narrative","volume":"392","author":"Ralston","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2026.107364_bib0125","first-page":"130","article-title":"The SEEN comprehensive clinical survey of adult obesity: executive summary","volume":"68","author":"Ballesteros Pomar","year":"2021","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"key":"10.1016\/j.medcli.2026.107364_bib0130","doi-asserted-by":"crossref","first-page":"E875","DOI":"10.1503\/cmaj.191707","article-title":"Obesity in adults: a clinical practice guideline","volume":"192","author":"Wharton","year":"2020","journal-title":"CMAJ"},{"key":"10.1016\/j.medcli.2026.107364_bib0135","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.diabet.2018.12.001","article-title":"Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: insights from the SUSTAIN 1-7 trials","volume":"45","author":"Aroda","year":"2019","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.medcli.2026.107364_bib0140","doi-asserted-by":"crossref","first-page":"S335","DOI":"10.37765\/ajmc.2020.88554","article-title":"Efficacy of oral semaglutide: overview of the PIONEER clinical trial program and implications for managed care","volume":"26","author":"Rodbard","year":"2020","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.medcli.2026.107364_bib0145","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.clinthera.2024.12.013","article-title":"Efficacy of oral medication in weight loss management: a systematic review and network meta-analysis","volume":"47","author":"Benedictus","year":"2025","journal-title":"Clin Ther"},{"key":"10.1016\/j.medcli.2026.107364_bib0150","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41366-024-01473-y","article-title":"What is the pipeline for future medications for obesity?","volume":"49","author":"Melson","year":"2025","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.medcli.2026.107364_bib0155","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(23)01185-6","article-title":"Oral semaglutide 50mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"402","author":"Knop","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2026.107364_bib0160","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s40519-024-01711-2","article-title":"Real-world effectiveness of semaglutide treatment on weight loss maintenance after weight loss in patients with obesity or overweight and diabetes","volume":"30","author":"Del Prete","year":"2025","journal-title":"Eat Weight Disord"},{"key":"10.1016\/j.medcli.2026.107364_bib0165","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1386542","article-title":"Transforming body composition with semaglutide in adults with obesity and type 2 diabetes mellitus","volume":"15","author":"Rodr\u00edguez Jim\u00e9nez","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.medcli.2026.107364_bib0170","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s13300-024-01668-6","article-title":"Oral semaglutide use in type 2 diabetes: a pooled analysis of clinical and patient-reported outcomes from seven PIONEER REAL prospective real-world studies","volume":"16","author":"Rudofsky","year":"2025","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.medcli.2026.107364_bib0175","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1593334","article-title":"Oral semaglutide for the treatment of obesity: a retrospective real-world study","volume":"16","author":"Krajnc","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.medcli.2026.107364_bib0180","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1007\/s11695-012-0682-4","article-title":"Validity of the Beck Depression Inventory as a screening tool for a clinical mood disorder in bariatric surgery candidates","volume":"22","author":"Hayden","year":"2012","journal-title":"Obes Surg"},{"key":"10.1016\/j.medcli.2026.107364_bib0185","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s11154-023-09796-3","article-title":"Relevance of body composition in phenotyping the obesities","volume":"24","author":"Salm\u00f3n-G\u00f3mez","year":"2023","journal-title":"Rev Endocr Metab Disord"},{"issue":"suppl 4","key":"10.1016\/j.medcli.2026.107364_bib0190","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/dom.15728","article-title":"Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies","volume":"26","author":"Neeland","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.medcli.2026.107364_bib0195","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1161\/CIRCULATIONAHA.124.067676","article-title":"Muscle mass and glucagon-like peptide-1 receptor agonists: adaptive or maladaptive response to weight loss?","volume":"150","author":"Linge","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.medcli.2026.107364_bib0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156057","article-title":"The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation","volume":"161","author":"Stefanakis","year":"2024","journal-title":"Metabolism"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002577532600014X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002577532600014X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:07:00Z","timestamp":1774620420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002577532600014X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S002577532600014X"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2026.107364","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world effectiveness of oral semaglutide on body weight, composition, and metabolic parameters in patients with obesity without diabetes","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2026.107364","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107364"}}